Search Results

FILTER BY

1 - 12 of 13 matches

Sort by:
  • PresentationTCT 2024

    TCT 230: Ticagrelor Monotherapy vs. Ticagrelor Plus Aspirin in Patients With Chronic Coronary Syndrome and High Ischemic Risk: A Post-Hoc Analysis of the TWILIGHT Trial

    Presenter:  

    Mauro Gitto

    October 27, 2024

  • PresentationTCT 2023

    Safety and Efficacy of Ticagrelor Monotherapy in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: An Individual Patient Data Meta-analysis of the TWILIGHT and TICO Randomized Trials

    Presenter:  

    Usman Baber

    October 23, 2023

  • PresentationControversies and Advances 2019

    Optimal DAPT Strategies: Lessons Learned, Global Leaders, TWILIGHT, and More

    Presenter:  

    Roxana Mehran

    November 15, 2019

  • PresentationTCT 2019

    STOPDAPT, SMART-CHOICE, and TWILIGHT: Will These Trials Change Your Clinical Practice?

    Presenter:  

    Aditya Kapoor

    September 28, 2019

  • PresentationTCT 2019

    Is it TWILIGHT for Aspirin? Critical Appraisal and Interpretation of the Trial

    Presenter:  

    Pascal Vranckx

    September 28, 2019

  • PresentationTCT 2019

    GLOBAL LEADERS: Ticagrelor Monotherapy vs. DAPT After PCI in TWILIGHT-Like Patients

    Presenter:  

    Yoshinobu Onuma

    September 27, 2019

  • PresentationTCT 2019

    TWILIGHT: A Deep Dive

    Presenter:  

    Usman Baber

    September 26, 2019

  • PresentationTCT 2019

    TWILIGHT Thrombogenicity Substudy: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI

    Presenter:  

    Usman Baber

    September 26, 2019

  • PresentationTCT 2019

    TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy vs. Ticagrelor-Plus-Aspirin Beginning at 3 Months in High-Risk Patients Undergoing PCI

    Presenter:  

    Roxana Mehran

    September 26, 2019

  • PresentationTCT 2019

    Insights From TWILIGHT

    Presenter:  

    Usman Baber

    September 26, 2019

  • PresentationTCT 2017

    Predicting the Future: Will the Ongoing TWILIGHT and GLOBAL LEADERS Trials Change The Current Recommended Approach to Chronic Antiplatelet Therapy?

    Presenter:  

    C. Michael Gibson, Eric R. Bates, Stephan Windecker

    October 30, 2017

  • PresentationTCT 2016

    Rationale for and Design of TWILIGHT and GLOBAL LEADERS: What I Expect the Findings to Be – But What Won’t Surprise Me!

    Presenter:  

    C. Michael Gibson, Jorge Gaspar

    October 30, 2016